首页> 外文期刊>Indian journal of Anaesthesia >Comparison of efficacy of palonosetron-dexamethasone combination with palonosetron or dexamethasone alone for prophylaxis against post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy
【24h】

Comparison of efficacy of palonosetron-dexamethasone combination with palonosetron or dexamethasone alone for prophylaxis against post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy

机译:帕洛诺司琼-地塞米松联合帕洛诺司琼或地塞米松单独预防腹腔镜胆囊切除术患者术后恶心和呕吐的疗效比较

获取原文
       

摘要

Background and Aims: Post-operative nausea and vomiting (PONV) is highly distressing and unpleasant symptom. Dexamethasone and palonosetron are effective antiemetics with minimal side effect profile. This study compares the efficacy of palonosetron or dexamethasone alone and their combination (palonosetron plus dexamethasone) for prevention of PONV after laparoscopic cholecystectomy. Methods: This prospective, randomised, double-blind trial was done on 187 adults, American Society of Anesthesiologists Grade I and II patients, aged 18–75 years undergoing laparoscopic cholecystectomy. They were allocated to three groups which were to receive either of the three treatment regimens: dexamethasone 8 mg (Group D, n = 57), palonosetron 0.075 mg (Group P, n = 66) or dexamethasone 8 mg plus palonosetron 0.075 mg (Group PD, n = 64). The primary outcome was incidence of PONV in 24 h and the secondary outcome was a number of rescue antiemetic required. One-way ANOVA test was used to compare the means amongst three groups. To compare the proportions in the groups, Chi-square test/Fisher's exact test/Two proportions Z-test was applied as appropriate. Results: Overall incidences of PONV in the study 24 h postoperatively were 23.4% in PD, 27.2% in P group and 56.14% in D group (P Conclusion: Palonosetron alone and palonosetron-dexamethasone combination were equally effective in the prevention of PONV. Dexamethasone alone was least effective amongst the three groups. There is no difference between palonosetron and palonosetron-dexamethasone for PONV prevention.
机译:背景与目的:术后恶心和呕吐(PONV)非常令人痛苦,症状不佳。地塞米松和帕洛诺司琼是有效的止吐药,副作用最小。这项研究比较了帕洛诺司琼或地塞米松及其组合(帕洛诺司琼加地塞米松)预防腹腔镜胆囊切除术后PONV的疗效。方法:这项前瞻性,随机,双盲试验是对187名年龄在18至75岁,接受腹腔镜胆囊切除术的美国麻醉医师协会I级和II级成年人进行的。将他们分为三组,分别接受三种治疗方案中的一种:地塞米松8 mg(D组,n = 57),帕洛诺司琼0.075 mg(P组,n = 66)或地塞米松8 mg加帕洛诺司琼0.075 mg(组) PD,n = 64)。主要结果是24小时内PONV的发生率,次要结果是需要大量的止吐药。单向方差分析用于比较三组的平均值。为了比较各组中的比例,适当地应用卡方检验/ Fisher精确检验/两个比例Z检验。结果:术后24 h PONV的总体发生率在PD组为23.4%,P组为27.2%,D组为56.14%(P结论:单独使用帕洛诺司琼和帕洛诺司琼-地塞米松联合治疗对PONV的预防效果相同。在三组中,单独使用效果最差,帕洛诺司琼和帕洛诺司琼-地塞米松在预防PONV方面没有差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号